Abstract
269 adult patients were included into the trial by the overall irrevocable sample method. 58%
patients were female. The frequency of atrial fibrillation (AF) was 14,9% (in females it is significantly
more frequent - 18,6%, in males - 9,7%). Clinical and social differences with and without
AF were detected between patients; part of them was possibly established by interconnected
with AF factor (the patient`s age) that is necessary to include in selecting of tactics for patients`
management. In general, medical treatment of patients is appropriate to recommendations of
ARSSC and worldwide practice as surgical methods of cardiovascular diseases (including AF)
are used rarely and don`t correspond to revealed necessities.
References
1. Бокерия, Л. А. Результаты эпидемиологического исследования «Структура болезней системы кровообращения и потребность в отдельных видах специализированной лечебно-диагностической помощи среди взрослых пациентов, обратившихся за медицинской помощью в государственные медицинские учреждения» (СТЕРХ) / Л. А. Бокерия, И. Н. Ступаков, И. В. Самородская// Грудная и серд.-сосуд. хир. - 2007. - № 5. - С. 4-8.
2. Клинические рекомендации по проведению электрофизиологических исследований, катетерной аблации и применению имплантируемых антиаритмических устройств. - М, 2009. - С. 239-303.
3. Baldasseronia, S. Age-Dependent art Failure: Data from the Italian Network on Congestive Heart Failure Registry / S. Baldasseronia, F. Orsoa, G. Fabbria et al. //Cardiology. - 2010. - Vol. 116, № 2. - P. 79-88.
4. Benjamin, E. J. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study /E. J. Benjamin, D. Levy, S. M. Vaziri et al. // JAMA. - 1994. - № 271. - P. 840-844.
5. Coyne, K. S. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States / K. S. Coyne, C. Paramore, S. Grandy et al. // Value Health. -2006. -Vol. 9. - P. 348-356.
6. Dublin, S. Risk of new-onset atrial fibrillation in relation to body mass index / S. Dublin, B. French, N. L. Glazer et al. // Arch. Intern. Med. - 2006. - Vol. 66. - P. 2322-2328.
7. Friberg, J. Rising rates of hospital admissions for atrial fibrillation /J. Friberg, P. Buch, H. Scharling et al. / Epidemiology. - 2003. - Vol. 14. - P. 666-672.
8. Hart, R. G. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention / R. G. Hart, J. L. Halperin // Ann. Intern. Med. - 1999. - Vol. 131. - P. 688-695 .
9. Kannel, W. B. Coronary heart disease and atrial fibrillation: The Framingham Study / W. B. Kannel, R. D. Abbott, D. D. Savage, P. M. McNamara// Amer. Heart J. - 1983. - Vol. 106. - P. 389-396.
10. LaPointe, N. M. A. Outpatient Use of Anticoagulants, Rate-Controlling Drugs, and Antiarrhythmic Drugs for Atrial Fibrillation. / N. M. A. LaPointe, L. Governale, J. Watkins et al. // Amer. Heart J. - 2007. - Vol. 154. - № 5. - P. 893-898.
11. Psaty, B. M. Incidence of and risk factors for atrial fibrillation in older adults / B. M. Psaty, T. A. Manolio, L. H. Kuller et al. // Circulation. - 1997. - Vol. 96. - P. 2455-2461.
12. Wang, T. J. Obesity and the risk of new-onset atrial fibrillation / T. J. Wang, H. Parise, D. Levy et al.// JAMA. -2004. -№ 292. - P. 2471-2477.
13. Wolf, P. A. Atrial fibrillation as an independent risk factor for stroke : the Framingham Study / P. A. Wolf, R. D. Abbott, W. B. Kannel // Stroke. - Vol. 22. - 1991. - P. 983-988.
